FILTER BY SCHOLARAll Scholars
- The following scholars have published material in this field
FILTER BY RELEVANCEMost Recent
FILTER BY CONTENT TYPEAll Content Types
The Indian government has threatened legal action against the authors of a paper on Indian drug export quality. This unfortunate response, if it proceeds, will ultimately hurt India, not the authors.
Drug quality is poorer among Indian-labelled drugs purchased inside African countries than among those purchased inside India or middle-income countries. Substandard drugs, which contain insufficient amounts of the active ingredient, are the biggest driver of this quality difference.
As Ebola comes to the US, AEI Resident Fellow Scott Gottlieb examines whether the US government dropped the ball on developing Ebola drugs on Fox Business Network's 'Willis Report.'
The Indian government must curb the flow of low-quality medications from Indian drug manufacturers to foreign markets. These substandard medicines provide ineffective treatment, at best, and endanger global health, at worst.
We welcome you to join us for a panel discussion of the undersea military competition occurring in Asia and what it means for the United States and its allies.
AEI’s Election Watch is back! Please join us for two sessions of the longest-running election program in Washington, DC.
We welcome you to join us at AEI for a discussion of what’s next for the Common Core.
Please join AEI for a discussion examining each candidate’s platform and prospects for victory and the impact that a possible shift toward free-market policies in Brazil might have on South America as a whole.